Boryung Pharmaceutical Co., Ltd

This study tests an experimental drug called BR101801 in 44 people with a rare type of blood cancer (peripheral T-cell lymphoma) that has returned or not responded to standard treatments. The main goal is to see how many patients have their tumors shrink or disappear. Participant…

This study tests five different doses of a new drug called BR1400 in 330 adults with high blood pressure (essential hypertension). The goal is to see how well each dose lowers blood pressure and how safe it is over 8 weeks. Participants must have a certain blood pressure range an…

This early-stage study will test a new drug combination for high blood pressure in 58 healthy adults. Participants will take the drugs by mouth after fasting, and researchers will measure drug levels in the blood to see how the body absorbs and processes them. The goal is to gath…

This early-stage study will give a single dose of a new blood pressure medication (BR1015) to 58 healthy adults. Researchers want to measure how the drug moves through the body and check for side effects. Participants must not have high blood pressure themselves. The goal is to g…

This early-stage study tests how two blood pressure medicines (BR1015-3 and BR1015-2) work when taken together compared to a combined pill. It involves 48 healthy adults and measures drug levels and safety. No treatment is given for high blood pressure—this is just to gather info…

This early-stage study tests a new combination of drugs for high blood pressure in 48 healthy adults. The goal is to see how the body absorbs and handles the drugs and to check for any safety issues. Participants will take the drugs by mouth after eating, and the study will compa…